Marker Therapeutics Competitors and Similar CompaniesClear all
Celldex Therapeutics's competitors and similar companies include Advaxis.
 Celldex Therapeutics Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development. | ||
Founding Date | Founding Date 1983 | Founding Date 2002 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Hampton, US HQ Fall River, US Needham, US New Haven, US | Locations Princeton, US HQ |
Employees | Employees 1608% increase | Employees 3540% decrease |
Valuation ($) | Valuation ($) 1.9 b | Valuation ($) 2.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $1.5m (FY, 2025) | Revenue (est.) $13k (FY, 2023) |
Cost of goods | Cost of goods $200k (FY, 2025) | Cost of goods $13k (FY, 2023) |
Net income | Net income ($258.8m) (FY, 2025) | Net income ($48.1m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 2m | Total funding raised $ 50.5m |
For sources of this data, please see the company profile
View Company Profiles
Advaxis
HQ
Princeton, US
Employees
35↓ 40% decrease
Advaxis is a biotechnology company developing the next generation of cancer immunotherapies.
View company